Citation: | DAI Si-yuan, JIANG Jie, HAN Rui, XU Jin-cheng. Expression and significance of heparanase, E-cadherin, and N-cadherin in oral squamous cell carcinoma[J]. Chinese Journal of General Practice, 2022, 20(6): 948-951. doi: 10.16766/j.cnki.issn.1674-4152.002495 |
[1] |
KHOWAL S, MONGA S, NAQVI S H, et al. Molecular winnowing, expressional analyses and interactome scrutiny of cellular proteomes of oral squamous cell carcinoma[J]. Adv Cancer Biol: Metastasis, 2021. DOI: 10.1016/j.adcanc.2021.100003.
|
[2] |
KESHAVARZI M, DARIJANI M, MOMENI F, et al. Molecular imaging and oral cancer diagnosis and therapy[J]. J Cell Biochem, 2017, 118(10): 3055-3060. doi: 10.1002/jcb.26042
|
[3] |
MASOLA V, ZAZA G, GAMBARO G, et al. Role of heparanase in tumor progression: Molecular aspects and therapeutic options[J]. Semin Cancer Biol, 2020, 62: 86-98. doi: 10.1016/j.semcancer.2019.07.014
|
[4] |
DATTA A, DENG S, GOPAL V, et al. Cytoskeletal dynamics in epithelial-mesenchymal transition: Insights into therapeutic targets for cancer metastasis[J]. Cancers(Basel), 2021, 13(8): 1882.
|
[5] |
XIA F, XU J C, ZHANG P, et al. Glucose-regulated protein 78 and heparanase expression in oral squamous cell carcinoma: Correlations and prognostic significance[J]. World J Surg Oncol, 2014, 12(1): 121. doi: 10.1186/1477-7819-12-121
|
[6] |
赵思语, 欧阳少波, 王军, 等. 口腔鳞状细胞癌组织中环状RNA的差异表达谱分析[J]. 口腔疾病防治, 2018, 26(2): 83-89. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYB201802004.htm
ZHAO S Y, OUYANG S B, WANG J, et al. Differential expression of circular RNA in oral squamous cell carcinoma[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2018, 26(2): 83-89. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYB201802004.htm
|
[7] |
VLODAVSKY I, ILAN N, NAGGI A, et al. Heparanase: Structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate[J]. Curr Pharm Des, 2007, 13(20): 2057-2073. doi: 10.2174/138161207781039742
|
[8] |
邱新峰, 程万民. HPA及NRF2与喉鳞状细胞癌发生和发展的相关性研究[J]. 重庆医学, 2018, 47(12): 1628-1631. doi: 10.3969/j.issn.1671-8348.2018.12.016
QIU X F, CHENG W M. Study on the relationship between HPA and NRF2 and the occurrence and development of laryngeal squamous cell carcinoma[J]. Chongqing Medicine, 2018, 47(12): 1628-1631. doi: 10.3969/j.issn.1671-8348.2018.12.016
|
[9] |
王孝忠, 刘丹, 胡喜珍, 等. Hpa的表达与子宫内膜癌侵袭性关系[J]. 中国妇产科临床杂志, 2017, 18(1): 29-32. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC201701010.htm
WANG X Z, LIU D, HU X Z, et al. Expression of heparanase and the invasive ability of endometrial carcinoma[J]. Chinese Journal of Clinical Obstetrics and Gynecology, 2017, 18(1): 29-32. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC201701010.htm
|
[10] |
TATSUMI Y, MIYAKE M, SHIMADA K, et al. Inhibition of heparanase expression results in suppression of invasion, migration and adhesion abilities of bladder cancer cells[J]. Int J Mol Sci, 2020, 21(11): 3789. doi: 10.3390/ijms21113789
|
[11] |
MIRZAEI S, ABADI A J, GHOLAMI M H, et al. The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets[J]. Eur J Pharmacol, 2021. DOI: 10.1016/j.ejphar.2021.174344.
|
[12] |
JAYANTHI P, VARUN B R, SELVARAJ J. Epithelial-mesenchymal transition in oral squamous cell carcinoma: An insight into molecular mechanisms and clinical implications[J]. J Oral Maxillofac Pathol, 2020, 24(1): 189. doi: 10.4103/jomfp.JOMFP_334_19
|
[13] |
张青云, 傅俊江, 陈汉春. 上皮间质转化介导肿瘤转移的分子机制[J]. 生命科学研究, 2018, 22(6): 503-510. https://www.cnki.com.cn/Article/CJFDTOTAL-SMKY201806011.htm
ZHANG Q Y, FU J J, CHEN H C. The molecular mechanism of epithelial-mesenchymal transition mediating tumor metastasis[J]. Life Science Research, 2018, 22(6): 503-510. https://www.cnki.com.cn/Article/CJFDTOTAL-SMKY201806011.htm
|
[14] |
LIU F, GU L N, SHAN B E, et al. Biomarkers for EMT and MET in breast cancer: An update[J]. Oncol Lett, 2016, 12(6): 4869-4876. doi: 10.3892/ol.2016.5369
|
[15] |
韩影影, 丁丹丹, 丁翔, 等. Livin表达与口腔鳞状细胞癌上皮间质转化的关系及其临床意义[J]. 中华全科医学, 2021, 19(3): 394-397. doi: 10.16766/j.cnki.issn.1674-4152.001819
HAN Y Y, DING D D, DING X, et al. Relationship between Livin expression and epithelial-mesenchymal transformation in oral squamous cell carcinoma and its clinical significance[J]. Chinese Journal of General Practice, 2021, 19(3): 394-397. doi: 10.16766/j.cnki.issn.1674-4152.001819
|
[16] |
申志华, 黄萨础拉, 马秀梅. 乙酰肝素酶、E-cadherin、N-cadherin和vimentin蛋白在胃癌中的表达及其意义[J]. 癌变·畸变·突变, 2020, 32(2): 98-104. doi: 10.3969/j.issn.1004-616x.2020.02.004
SHEN Z H, HUANG S, MA X M. Expression of heparanase, E-cadherin, N-cadherin and vimentin in gastric cancers[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(2): 98-104. doi: 10.3969/j.issn.1004-616x.2020.02.004
|
[17] |
CHEN X D, ZHAO H C, CHEN C Z, et al. The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation[J]. Oncol Lett, 2020, 19(1): 211-220.
|
[18] |
WANG C, WEI Y J, WANG G, et al. Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial-to-mesenchymal transition through the Wnt/β-catenin pathway[J]. Oncol Rep, 2020, 44(2): 711-721. doi: 10.3892/or.2020.7641
|
[19] |
MASOLA V, ZAZA G, GAMBARO G, et al. Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury[J]. PLoS One, 2016, 11(7): e0160074. doi: 10.1371/journal.pone.0160074
|